These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2447655)

  • 1. [Predicting changes in hemodynamics and anti-arrhythmic effectiveness of neogilurytmal].
    Nesvetov VN; Shpektor AV; Gorshkov VA
    Sov Med; 1987; (10):36-9. PubMed ID: 2447655
    [No Abstract]   [Full Text] [Related]  

  • 2. [The efficacy of propaphenol in extrasystole in patients with ischemic heart disease].
    Dobrotvorskaia TE; Rybakova MK; Suprun EK; Arifullin ShS
    Ter Arkh; 1992; 64(12):30-2. PubMed ID: 1284005
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative effectiveness of neogilurytmal, novocainamide, ethmozin, disopyramide and ethacizin in supraventricular extrasystole].
    Shpektor AV; Gorshkov VA; Mamaev VI; Sherashov VS; Kurakina TI
    Sov Med; 1986; (12):96-7. PubMed ID: 2436318
    [No Abstract]   [Full Text] [Related]  

  • 4. [When should heart failure be treated with anti-arrhythmia agents? Can the prognosis be improved?].
    Meinertz T
    Internist (Berl); 1990 Mar; 31(3 Suppl [ Anniv No TIARRH):12-4; discussion 14-5. PubMed ID: 1693602
    [No Abstract]   [Full Text] [Related]  

  • 5. [The pharmacodynamics of anti-arrhythmia preparations and their different combinations when administered intravenously].
    Abdalla A; Mazur NA; Iavorskaia NV; Kheĭmets GI; Chikovani SI; Potekhin EG
    Ter Arkh; 1992; 64(8):20-5. PubMed ID: 1279828
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of various anti-arrhythmia drugs on central hemodynamics during aortocoronary bypass and their effectiveness in the prevention of arrhythmia].
    Buniatian AA; Seleznev MN; Kalina GI; Flerov EV; Iulovskiĭ MS
    Anesteziol Reanimatol; 1981; (4):13-7. PubMed ID: 6175253
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experience with the clinical use of lithium oxybutyrate in patients with cardiac rhythm disorders].
    Petrova TR; Skibitskiĭ VV; Grigor'ev GI; Vil'chinskaia MN; Oleĭnik NI
    Ter Arkh; 1987; 59(6):115-9. PubMed ID: 2442827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative evaluation of the anti-arrhythmia effect of the antioxidant ionol (dibunol) in the arrhythmic form of neurocirculatory asthenia and stable exertion-induced stenocardia].
    Meerson FZ; Korochkin IM; Barbarash OL
    Sov Med; 1990; (3):67-70. PubMed ID: 1695023
    [No Abstract]   [Full Text] [Related]  

  • 9. [Various aspects of the anti-arrhythmia action of trimecaine and its effect on hemodynamics].
    Kostin IaV; Oleĭnikov VE; Sernov LN; Tatarchenko IP; Gendenshteĭn EI
    Farmakol Toksikol; 1984; 47(1):47-50. PubMed ID: 6200357
    [No Abstract]   [Full Text] [Related]  

  • 10. [The physician and extrasystole].
    Rullière R; Lancelin B
    Rev Prat; 1975 Apr; 25(23):1737-40, 1743-6, 1751-2 passim. PubMed ID: 49074
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hemodynamic effects of class-I and class-III anti-arrhythmia agents].
    Schmidt G; Honerjäger P; Niesel T
    Dtsch Med Wochenschr; 1989 Jun; 114(26):1040-5. PubMed ID: 2661189
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anti-arrhythmic effect of competitive aldosterone antagonists].
    Merzon AK; Khorunzhaia LV; Doviner AD; Berezov VM
    Vrach Delo; 1984 Apr; (4):18-22. PubMed ID: 6204456
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effectiveness and action characteristics of ethmozine in the treatment of children with extrasystole].
    Galstian AA; Aslanian AV
    Pediatriia; 1988; (7):49-52. PubMed ID: 2464790
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiac and side effects of prostaglandin F2 alpha in patients with extrasystoles.
    Sziegoleit W; Lange R; Hofmann H
    Biomed Biochim Acta; 1988; 47(10-11):S133-6. PubMed ID: 2470352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous variability of premature ventricular complexes and its significance in assessing anti-arrhythmic drug efficacy.
    Dai CZ; Zhang YL; Zeng B; Lu YX
    Chin Med J (Engl); 1989 Apr; 102(4):273-7. PubMed ID: 2477200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experience with the combined use of 1st- and 2d-group anti-arrhythmic preparations in patients with refractory arrhythmia].
    Abdalla A; Mazur NA
    Klin Med (Mosk); 1988 Jun; 66(6):40-3. PubMed ID: 2460667
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anti-arrhythmic activity of atropine, ritmilen, obsidan and cordarone in patients with ventricular allorhythmia].
    Antiu'fev VF; Arkhipov MV
    Klin Med (Mosk); 1989 Jun; 67(6):112-7. PubMed ID: 2476585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness of propafenon and disopyramide in ventricular extrasystole. Comparative study].
    Kenedi P
    MMW Munch Med Wochenschr; 1982 Aug; 124(34):734-6. PubMed ID: 6182460
    [No Abstract]   [Full Text] [Related]  

  • 19. Is ramipril anti-arrhythmic?
    O'Brien MM
    Aust Fam Physician; 1997 Aug; 26(8):987. PubMed ID: 9267066
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical studies with propafenone--a new antiarrhythmic agent.
    Prabhakaran SN; Bhatia ML
    Indian Heart J; 1984; 36(2):107-10. PubMed ID: 6202621
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.